Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy NovaBay Pharmaceuticals stock
Learn how to easily invest in NovaBay Pharmaceuticals stock.
NovaBay Pharmaceuticals Inc is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. NovaBay Pharmaceuticals employs 29 staff and has a trailing 12-month revenue of around $10.2 million.
How to buy shares in NovaBay Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NBY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NovaBay Pharmaceuticals stock price (NYSE MKT: NBY)Use our graph to track the performance of NBY stocks over time.
NovaBay Pharmaceuticals shares at a glance
|Latest market close||$0.11|
|52-week range||$0.10 - $0.66|
|50-day moving average||$0.23|
|200-day moving average||$0.27|
|Wall St. target price||$2.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.11|
Buy NovaBay Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NovaBay Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NovaBay Pharmaceuticals price performance over time
|1 week (2022-09-23)||0.45%|
|1 month (2022-09-01)||-51.85%|
|3 months (2022-07-01)||-58.03%|
|6 months (2022-04-01)||-62.67%|
|1 year (2021-10-01)||-81.80%|
|2 years (2020-10-01)||-84.75%|
|3 years (2019-10-01)||0.56|
|5 years (2017-09-29)||4.6|
NovaBay Pharmaceuticals financials
|Revenue TTM||$10.2 million|
|Gross profit TTM||$5.6 million|
|Return on assets TTM||-35.63%|
|Return on equity TTM||-34.97%|
|Market capitalisation||$6.2 million|
TTM: trailing 12 months
NovaBay Pharmaceuticals share dividends
We're not expecting NovaBay Pharmaceuticals to pay a dividend over the next 12 months.
Have NovaBay Pharmaceuticals's shares ever split?
NovaBay Pharmaceuticals's shares were split on a 1:25 basis on 20 December 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.
NovaBay Pharmaceuticals share price volatility
Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.1 up to $0.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 2.7779. This would suggest that NovaBay Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NovaBay Pharmaceuticals overview
NovaBay Pharmaceuticals, Inc. , a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals in the news
Life Sciences Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
Life Sciences Virtual Investor Conference Agenda Announced for September 15th
Frequently asked questionsWhat percentage of NovaBay Pharmaceuticals is owned by insiders or institutions?
Currently 19.849% of NovaBay Pharmaceuticals shares are held by insiders and 3.205% by institutions. How many people work for NovaBay Pharmaceuticals?
Latest data suggests 29 work at NovaBay Pharmaceuticals. When does the fiscal year end for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals's fiscal year ends in December. Where is NovaBay Pharmaceuticals based?
NovaBay Pharmaceuticals's address is: 2000 Powell Street, EmeryVille, CA, United States, 94608 What is NovaBay Pharmaceuticals's ISIN number?
NovaBay Pharmaceuticals's international securities identification number is: US66987P2011 What is NovaBay Pharmaceuticals's CUSIP number?
NovaBay Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 628729105
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert